Chiesi Ventures

VC · Boston (United States)

VC

Seed

Series A

Sign up free to access full profile and submit your pitch.

About

Chiesi Ventures is a venture capital arm of Chiesi Farmaceutici S. p. A., specializing in seed rounds to Series A, start-ups, and early stage investments. The firm typically focuses on small private entities. It seeks to invest in companies providing services and treatments for rare diseases, rare and orphan disorders, rare and orphan indications. The firm primarily invests in medical testing, traditional small molecules and biologics, development of new chemical entities and new biological entities, advanced therapies, reformulation technological platforms and devices, tools and services that help disease discovery, diagnosis, and management. Within small molecules and biologics sector, the firm focuses on early stage treatments in discovery, pre-clinical, and early clinical stage. It focuses on proprietary animal models, animal models predictive of for clinical, formulation adequate to state of development. Within advanced therapies, the firm invests in preclinical and early clinical stage with a focus on safety of vectors to transport genes or new cultures to breed stem cells, unencumbered intellectual property, a clinical plan minimizing time to regulatory submission and compliant to the new FDA and EMA guidelines on advanced medicinal products. Within reformulation technological platforms and devices, the firm seeks to invest in preclinical and early clinical stage. It typically invests in Unites States and Europe. It typically makes equity investments up to $4 million to $5 million and reserve a portion of funds for future rounds. For larger investments, the firm may act as a lead investor and syndicate investment in a certain round, even more so for one of our portfolio companies. Chiesi Ventures was founded on September 2, 2014 and is based in Boston, Massachusetts with additional offices in Research Triangle Park, North Carolina and Parma, Italy.

Investment Criteria